See more : Postmedia Network Canada Corp. (PNC-B.TO) Income Statement Analysis – Financial Results
Complete financial analysis of LiveWire Ergogenics, Inc. (LVVV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LiveWire Ergogenics, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Jetpak Top Holding AB (publ) (JETPAK.ST) Income Statement Analysis – Financial Results
- SAS Florentaise (ALFLO.PA) Income Statement Analysis – Financial Results
- Linocraft Holdings Limited (8383.HK) Income Statement Analysis – Financial Results
- Sunniva Inc. (SNNVF) Income Statement Analysis – Financial Results
- Yantai Zhenghai Magnetic Material Co., Ltd. (300224.SZ) Income Statement Analysis – Financial Results
LiveWire Ergogenics, Inc. (LVVV)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://livewireergogenics.com
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. The company is based in Anaheim, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.63M | 1.94M | 851.20K | 580.32K | 344.23K | 35.71K | 0.00 | 9.07K | 45.13K | 238.96K | 146.17K | 148.03K | 402.34K | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 39.38K | 133.17K | 149.65K | 203.81K | 147.21K | 177.92K | 0.00 | 8.00K | 49.95K | 240.62K | 93.59K | 137.02K | 258.48K | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 1.59M | 1.80M | 701.55K | 376.51K | 197.03K | -142.21K | 0.00 | 1.07K | -4.82K | -1.66K | 52.58K | 11.02K | 143.86K | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 97.59% | 93.13% | 82.42% | 64.88% | 57.24% | -398.24% | 0.00% | 11.83% | -10.69% | -0.70% | 35.97% | 7.44% | 35.76% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 841.88K | 1.55M | 7.92M | 768.27K | 0.00 | 0.00 | 2.83M | 869.13K | 1.61M | 524.16K | 121.36K | 42.67K | 116.14K | 142.48K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 841.04K | 1.23M | 0.00 | 0.00 | 0.00 | 0.00 | 55.76K | 64.68K | 69.93K | 10.27K | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 764.38K | 1.16M | 3.19M | 841.88K | 1.23M | 7.92M | 768.27K | 19.90K | 336.36K | 2.88M | 933.81K | 1.68M | 534.43K | 121.36K | 42.67K | 116.14K | 142.48K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 764.38K | 1.16M | 3.19M | 841.88K | 1.23M | 7.92M | 768.27K | 19.90K | 336.36K | 2.89M | 940.89K | 1.68M | 534.43K | 121.36K | 42.67K | 130.84K | 163.50K |
Cost & Expenses | 803.76K | 1.29M | 3.34M | 1.05M | 1.38M | 8.10M | 768.27K | 27.90K | 386.32K | 3.13M | 1.03M | 1.82M | 792.90K | 121.36K | 42.67K | 130.84K | 163.50K |
Interest Income | 346.91K | 288.64K | 178.32K | 33.17K | 0.00 | 747.81K | 474.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 245.32K | 249.24K | 605.21K | 666.38K | 1.05M | 0.00 | 0.00 | 59.46K | 153.32K | 653.92K | 59.20K | 21.02K | 2.38K | 10.94K | 0.00 | 11.00K | 0.00 |
Depreciation & Amortization | 39.38K | 133.17K | 149.65K | 163.81K | 137.02K | 117.87K | 768.27K | 1.28K | 4.34K | 4.66K | 7.08K | 6.20K | 3.90K | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | 1.22M | 1.07M | -2.68M | -301.56K | -515.48K | -10.73M | 41.80K | -17.55K | -332.69K | -3.30M | -881.23K | -1.67M | -386.66K | -121.36K | -32.67K | -130.84K | -163.50K |
EBITDA Ratio | 74.45% | 40.14% | -275.00% | -51.96% | -260.77% | -22,255.68% | 0.00% | -193.47% | -746.40% | -1,207.30% | -602.89% | -1,124.52% | -96.10% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 829.99K | 644.73K | -2.49M | -465.37K | -1.03M | -8.07M | -768.27K | -18.83K | -341.19K | -2.89M | -888.31K | -1.67M | -390.56K | -121.36K | -52.67K | -130.84K | -163.50K |
Operating Income Ratio | 50.80% | 33.27% | -292.58% | -80.19% | -300.57% | -22,585.76% | 0.00% | -207.58% | -756.02% | -1,209.25% | -607.73% | -1,128.71% | -97.07% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 91.59K | 39.39K | -941.99K | -1.16M | -672.00K | -3.53M | -432.65K | -59.45K | -149.16K | -1.29M | -377.63K | -31.92K | -2.38K | 0.00 | 10.00K | 0.00 | 0.00 |
Income Before Tax | 921.58K | 684.12K | -3.43M | -1.62M | -1.71M | -11.59M | -1.20M | -78.28K | -490.34K | -4.18M | -1.27M | -1.70M | 0.00 | 0.00 | -42.67K | 0.00 | 0.00 |
Income Before Tax Ratio | 56.41% | 35.30% | -403.25% | -279.33% | -495.79% | -32,464.82% | 0.00% | -863.01% | -1,086.51% | -1,750.74% | -866.08% | -1,150.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -5.00 | 4.00 | 4.00 | -20.11K | 68.97K | -4.00 | -769.81K | -1.00 | 0.00 | 653.92K | 59.20K | 21.02K | 2.38K | 121.36K | -10.00K | 156.84K | 152.62K |
Net Income | 921.58K | 684.12K | -3.43M | -1.60M | -1.78M | -11.59M | -1.20M | -78.28K | -490.34K | -4.18M | -1.27M | -1.70M | -392.95K | -121.36K | -32.67K | -156.84K | -152.62K |
Net Income Ratio | 56.41% | 35.30% | -403.25% | -275.87% | -515.83% | -32,464.82% | 0.00% | -863.01% | -1,086.51% | -1,750.74% | -866.08% | -1,150.28% | -97.66% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -0.03 | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 | -0.03 | -0.03 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -0.03 | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 | -0.03 | -0.03 |
Weighted Avg Shares Out | 1.85B | 1.79B | 1.58B | 1.20B | 1.11B | 952.71M | 682.73M | 527.12M | 284.80M | 133.04M | 75.07M | 65.12M | 57.73M | 36.00M | 5.92M | 5.92M | 5.92M |
Weighted Avg Shares Out (Dil) | 1.94B | 1.88B | 1.58B | 1.20B | 1.11B | 952.71M | 682.73M | 527.12M | 284.80M | 133.04M | 75.07M | 65.12M | 57.73M | 36.00M | 5.92M | 5.92M | 5.92M |
Livewire Ergogenics Introduces “Sol Vida Spray” First-of-its-Kind Cannabis Elixir Spray
LiveWire Ergogenics Announces Delivery of First Harvest from Estrella River Farms
LiveWire Ergogenics Announces Delivery of First Harvest from Estrella River Farms
LiveWire Ergogenics Releases Exclusive Video Tour of the World's First Estate Grown Weedery
LiveWire Ergogenics Executes Letter of Intent to Acquire Equity Position in Makana Ola Farms Located in Humboldt California
LiveWire Ergogenics Publishes Seven Months in the Life of LiveWire and Estrella River Farms
LiveWire Ergogenics Enters Consulting and Marketing Service Agreement with Makana Ola Farms Located in Humboldt California
LiveWire Ergogenics Files New Regulation A Offering
LiveWire Ergogenics Announces Final Approval to Operate a Commercial Cannabis Business in the County of San Luis Obispo California
LiveWire Ergogenics Reports Q1 2021 Financial Performance Provides Update on Permit Application Process
Source: https://incomestatements.info
Category: Stock Reports